Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Artificial Tears Market in China 2021
15 March 2021
The artificial tears market in China in terms of revenue is set to grow by US$ 514 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 13.2% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for artificial tears. The China artificial tears market is segmented on the basis of type. By type, it is categorized into sodium hyaluronate, and others.
The report has profiled some of the key players of the market such as URSAPHARM Arzneimittel GmbH, Santen Pharmaceutical Co. Ltd..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the artificial tears market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Type: sodium hyaluronate, and others
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the China artificial tears market
Pinpoint growth sectors and trends for investment
Understand what the future of the artificial tears market in China looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Artificial Tears Market by Type
4.1 Sodium Hyaluronate
5. Company Profiles
5.1 URSAPHARM Arzneimittel GmbH
5.2 Santen Pharmaceutical Co., Ltd.
6.1 About StrategyHelix